Trailblazing the path to transcription factors by intervening at a previously hidden region we have identified as the ‘switch site.’
© 2024 FLARE THERAPEUTICS INC. ALL RIGHTS RESERVED.
SWITCHING
THE VIEW
To date, the collective research on transcription factors has been elusive to drug discovery. However, Flare Therapeutics has now reached a moment of light – with the prospect of forever changing the trajectory of how we treat disease.
Flare Therapeutics’ pipeline is Initially focused on precision oncology.
Our small molecules are designed to regain transcriptional control that is hijacked by cancer.
ENLIGHTEN
YOUR PATH
Intensity, empathy, determination, and brilliance. The Flare Therapeutics team is a living, growing, thriving organization of talented people and bright minds. We are always looking for new sparks to flame our collective fire. Learn more about our culture and join us!
04.09.2024
Flare Therapeutics Presents Data at AACR 2024 Annual Meeting Characterizing PPARG-Derived Immune Cell Patterns in Urothelial Cancer Patients After Anti-PD1 Therapy
This links to an external website.